| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |